Prevalence, incidence and adherence of difficult-to-treat adult asthma in the Netherlands

Prevalence, incidence and adherence of *difficult-to-treat* adult asthma in the Netherlands - Prevalence, incidence and adherence of *difficult-to-treat* adult asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38002

Enrollment

6000

Registered

2012-03-26

Start date

2011-05-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma obstructive airway disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients registerd in the 73 participating pharmacies using inhaled corticosteroids

Exclusion criteria

Exclusion criteria: patients with COPD will be excluded

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: Study 1: the prevalence and incidence of patients with difficult-to-treat asthma (cases/10.000 inhabitants) in the Netherlands. Study 2: factors associated with adherence to pulmonary medication in difficult-to-treat asthma. Study 3: inhalation technique scores in adherent patients with difficult-to-treat asthma Study 4: To assess the prevalence of patients with truly severe, refractory asthma and describe the characteristics of these patients	—

Measure

Time frame

Main study parameters/endpoints: Study 1: the prevalence and incidence of patients with difficult-to-treat asthma (cases/10.000 inhabitants) in the Netherlands. Study 2: factors associated with adherence to pulmonary medication in difficult-to-treat asthma. Study 3: inhalation technique scores in adherent patients with difficult-to-treat asthma Study 4: To assess the prevalence of patients with truly severe, refractory asthma and describe the characteristics of these patients

—

Countries

Netherlands

Outcome results